Smithfield Trust’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5K Sell
11,480
-2,403
-17% -$2.51K ﹤0.01% 999
2025
Q4
$21K Buy
+13,883
New +$29.7K ﹤0.01% 755

Other funds holding MDCX

Smithfield Trust's MDCX Position: Q1 2026 in Review

Smithfield Trust reduced its Medicus Pharma (MDCX) stake by 17% in Q1 2026, selling an estimated $2.51K and leaving 11,480 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Smithfield Trust first reported a position in MDCX in Q4 2025 and has held it in 2 quarters since. The position peaked at $21K in Q4 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

  • Smithfield Trust held 11,480 shares of Medicus Pharma worth $5K as of Q1 2026.
  • Smithfield Trust sold 2,403 Medicus Pharma shares in Q1 2026, an estimated $2.51K.
  • Medicus Pharma made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #999 holding.
  • Smithfield Trust first reported a position in Medicus Pharma in Q4 2025 and has held it in 2 quarters since.
  • Smithfield Trust's Medicus Pharma position peaked at $21K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.